[The addiction potential of benzodiazepines. Application of the results of treatment of alcohol withdrawal syndrome].
A benzodiazepine withdrawal syndrome was demonstrated in this study. It occurred more frequently with use of the short-acting type of benzodiazepine and approximately 26 hours after discontinuing the regular intake of the drug as compared with approximately 4 days after stopping the regular intake of the long-acting type of benzodiazepine. These findings have a special significance in the treatment of the alcohol withdrawal syndrome, since 30% of alcoholics have been shown to have a regular intake of one of the benzodiazepines and since these are the drugs of choice in the treatment of the syndrome.
D000430:Alcohol Withdrawal Delirium / Q000188:drug therapy*; D001569:Benzodiazepines; D002707:Chlordiazepoxide / Q000009:adverse effects / Q000097:blood; D006801:Humans; D010076:Oxazepam / Q000009:adverse effects / Q000097:blood; D011604:Psychoses, Alcoholic / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders; D013997:Time Factors
D001569:Benzodiazepines; D010076:Oxazepam; D002707:Chlordiazepoxide
Die afhanklikheidspotensiaal van die bensodiasepiene. Toepassing van die resultate van die behandeling van die alkohol-onttrekkingsindroom.